A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of the topical antibiotic LTX-109 in
terms of clinical and microbiological response in treatment of impetigo.